The staphostatin family of cysteine protease inhibitors in the genus Staphylococcus as an example of parallel evolution of protease and inhibitor specificity

Biological Chemistry

Volumn 388, Issue 2, 2007, Pages 227-235

  Dubin, Grzegorz ^a   Wladyka, Benedykt ^a   Stec Niemczyk, Justyna ^a   Chmiel, Dorota ^a   Zdzalik, Michal ^a   Dubin, Adam ^a   Potempa, Jan ^a,b  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b University of Georgia ^*  (United States)

Author keywords

Cysteine protease inhibitors; Cysteine proteases; Regulation of proteolysis; Staphostatins; Staphylococci

Indexed keywords

CYSTEINE PROTEINASE INHIBITOR; LIPOCALIN; STAPHOSTATIN A; STAPHOSTATIN B; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; GENE DUPLICATION; GENE FREQUENCY; INHIBITION KINETICS; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; STAPHYLOCOCCUS AUREUS;

ANIMALS; BACTERIAL PROTEINS; BIOLOGICAL EVOLUTION; CARRIER PROTEINS; CHICKENS; CLONING, MOLECULAR; CYSTEINE ENDOPEPTIDASES; OPERON; POLYMERASE CHAIN REACTION; PROTEASE INHIBITORS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS; SUBSTRATE SPECIFICITY;

STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS WARNERI;

EID: 33846567123     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2007.025     Document Type: Article

References (32)

1. Arvidson, S., Holme, T., and Lindholm, B. (1973). Studies on extracellular proteolytic enzymes from Staphylococcus aureus. I. Purification and characterization of one neutral and one alkaline protease. Biochim. Biophys. Acta 302, 135-148.
2. Bieth, J. (1974). Some kinetic consequences of the tight binding of protein-proteinase-inhibitors to proteolytic enzymes and their application to the determination of dissociation constants. In: Bayer-Symposium V: Proteinase Inhibitors, H. Fritz, H. Tschesche, L.J. Greene and E. Truscheit, eds. (Berlin, Germany: Springer-Verlag), pp. 463-469.
3. Bieth, J.G. (1980). Pathophysiological interpretation of kinetic constants of protease inhibitors. Bull. Eur. Physiopathol. Respir. 16 (Suppl.), 183-195.
4. Calander, A.M., Jonsson, I.M., Kanth, A., Arvidson, S., Shaw, L., Foster, S.J., and Tarkowski, A. (2004). Impact of staphylococcal protease expression on the outcome of infectious arthritis. Microbes Infect. 6, 202-206.
5. Coulter, S.N., Schwan, W.R., Ng, E.Y., Langhorne, M.H., Ritchie, H.D., Westbrock-Wadman, S., Hufnagle, W.O., Folger, K.R., Bayer, A.S., and Stover, C.K. (1998). Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments. Mol. Microbiol. 30, 393-404.
6. Dubin, G., Chmiel, D., Mak, P., Rakwalska, M., Rzychon, M., and Dubin, A. (2001). Molecular cloning and biochemical characterization of proteases form Staphylococcus epidermidis. Biol. Chem. 382, 1575-1582.
7. Dubin, G., Krajewski, M., Popowicz, G., Stec-Niemczyk, J., Bochtler, M., Potempa, J., Dubin, A., and Holak, T.A. (2003). A novel class of cysteine protease inhibitors: solution structure of staphostatin A from Staphylococcus aureus. Biochemistry 42, 13449-13456.
8. Dubin, G., Stec-Niemczyk, J., Dylag, T., Silberring, J., Dubin, A., and Potempa, J. (2004). Characterisation of a highly specific, endogenous inhibitor of cysteine protease from Staphylococcus epidermidis, a new member of the staphostatin family. Biol. Chem. 385, 543-546.
9. Easson, L.H. and Stedman, E. (1936). The absolute activity of choline-esterase. Proc. R. Soc. B, 121, 141-164.
10. Filipek, R., Rzychon, M., Oleksy, A., Gruca, M., Dubin, A., Potempa, J., and Bochtler, M. (2003). The staphostatin-staphopain complex: a forward binding inhibitor in complex with its target cysteine protease. J. Biol. Chem. 278, 40959-40966.
11. Filipek, R., Potempa, J., and Bochtler, M. (2005). A comparison of staphostatin B with standard mechanism serine protease inhibitors. J. Biol. Chem. 280, 14669-14674.
12. Golonka, E., Filipek, R., Sabat, A., Sinczak, A., and Potempa, J. (2004). Genetic characterization of staphopain genes in Staphylococcus aureus. Biol. Chem. 385, 1059-1067.
13. Hayes, F. (2003). Toxins-antitoxins: plasmid maintenance, programmed cell death, and cell cycle arrest. Science 301, 1496-1499.
14. 2 coordinative bond. J. Biol. Chem. 276, 35087-35092.
15. Henderson, P.F. (1972). A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors. Biochem. J. 127, 321-333.
16. Kagawa, T.F., O'Toole, P.W., and Cooney, J.C. (2005). SpeB-Spi: a novel protease-inhibitor pair from Streptococcus pyogenes. Mol. Microbiol. 57, 650-666.
17. Massimi, I., Park, E., Rice, K., Muller-Esterl,W., Sauder, D.N, and McGavin, M.J. (2002). Identification of a novel maturation mechanism and restricted substrate specificity for the SspB cysteine protease of Staphylococcus aureus. J. Biol. Chem. 277, 41770-41777.
18. Potempa, J., Dubin, A., Korzus, G., and Travis, J. (1988). Degradation of elastin by a cysteine proteinase form Staphylococcus aureus. J. Biol. Chem. 263, 2664-2667.
19. Potempa, J., Golonka, E., Filipek, R., and Shaw, L.N. (2005). Fighting an enemy within: cytoplasmic inhibitors of bacterial cysteine proteases. Mol. Microbiol. 57, 605-610.
20. Rice, K., Perlata, R., Bast, D., Azavedo, J., and McGavin, M.J. (2001). Description of staphylococcus serine protease (ssp) operon in Staphylococcus aureus and nonpolar inactivation of sspA-encoded serine protease. Infect. Immun. 69, 159-169.
21. Rzychon, M., Filipek, R., Sabat, A., Kosowska, K., Dubin, A., Potempa, J., and Bochtler, M. (2003a). Staphostatins resemble lipocalins, not cystatins in fold. Protein Sci. 12, 2252-2256.
22. Rzychon, M., Sabat, A., Kosowska, K., Potempa, J., and Dubin, A. (2003b). Staphostatins: an expanding new group of proteinase inhibitors with a unique specificity for the regulation of staphopains, Staphylococcus spp. cysteine proteinases. Mol. Microbiol. 49, 1051-1066.
23. Sabat, A., Kosowska, K., Poulsen, K., Kasprowicz, A., Sekowska, A., van Den Burg, B., Travis, J., and Potempa, J. (2000). Two allelic forms of the aureolysin gene (aur) within Staphylococcus aureus. Infect Immun. 68, 973-976.
24. Schechter, I. and Berger, A. (1967). On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27, 157-162.
25. Sifri, C.D., Begun, J., Ausubel, F.M., and Calderwood, S.B. (2003). Caenorhabditis elegans as a model host for Staphylococcus aureus pathogenesis. Infect. Immun. 71, 2208-2217.
26. Shaw, L., Golonka, E., Potempa, J., and Foster, S.J. (2004). The role and regulation of the extracellular proteases of Staphylococcus aureus. Microbiology 150, 217-228.
27. Shaw, L.N., Golonka, E., Szmyd, G., Foster, S.J., Travis, J., and Potempa, J. (2005). Cytoplasmic control of premature activation of a secreted protease zymogen: deletion of staphostatin B (SspC) in Staphylococcus aureus 8325-4 yields a profound pleiotropic phenotype. J. Bacteriol. 187, 1751-1762.
28. Takeuchi, S., Kinoshita, T., Kaidoh, T., and Hashizume, N. (1999). Purification and characterization of protease produced by Staphylococcus aureus isolated from a diseased chicken. Vet. Microbiol. 67, 195-202.
29. Takeuchi, S., Matsunaga, K., Inubushi, S., Higuchi, H., Imaizumi, K., and Kaidoh, T. (2002). Structural gene and strain specificity of a novel cysteine protease produced by Staphylococcus aureus isolated from a diseased chicken. Vet. Microbiol. 89, 201-210.
30. Watson, S.P., Clements, M.O., and Foster, S.J. (1998). Characterization of the starvation-survival response of Staphylococcus aureus. J. Bacteriol. 180, 1750-1758.
31. Wladyka, B., Puzia, K., and Dubin, A. (2005). Efficient co-expression of a recombinant staphopain A and its inhibitor staphostatin A in Escherichia coli. Biochem. J. 385, 181-187.
32. Yokoi, K., Kakikawa, M., Kimoto, H., Watanabe, K., Yasukawa, H., Yamakawa, A., Taketo, A., and Kodaira, K.I. (2001). Genetic and biochemical characterization of glutamyl endopeptidase of Staphylococcus warneri M. Gene 281, 115-122.